Medtronic to announce financial results for its third quarter of fiscal year 2025
Medtronic (NYSE: MDT) has announced it will release its third quarter fiscal year 2025 financial results on Tuesday, February 18, 2025. The earnings release will be available at 5:45 a.m. CST, followed by a video webcast at 7:00 a.m. CST to discuss the results for the quarter that ended January 24, 2025.
The company has also outlined its upcoming earnings release schedule, including Q4 FY2025 results on May 21, 2025, and quarterly results for FY2026 scheduled for August 19, 2025, November 18, 2025, February 17, 2026, and May 20, 2026.
Medtronic, headquartered in Galway, Ireland, is a global healthcare technology company with 95,000+ employees across 150+ countries. Their technologies treat 70 health conditions, including cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems.
Medtronic (NYSE: MDT) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre dell'anno fiscale 2025 martedì 18 febbraio 2025. Il comunicato sugli utili sarà disponibile alle 5:45 CST, seguito da una trasmissione video in webcast alle 7:00 CST per discutere dei risultati per il trimestre che si è concluso il 24 gennaio 2025.
L'azienda ha anche delineato il suo programma di rilascio degli utili, inclusi i risultati del Q4 FY2025 il 21 maggio 2025, e i risultati trimestrali per FY2026 previsti per il 19 agosto 2025, 18 novembre 2025, 17 febbraio 2026 e 20 maggio 2026.
Medtronic, con sede a Galway, Irlanda, è un'azienda globale di tecnologia sanitaria con oltre 95.000 dipendenti in oltre 150 paesi. Le loro tecnologie trattano 70 condizioni di salute, comprese le dispositivi cardiaci, la robotica chirurgica, le pompe per insulina e i sistemi di monitoraggio dei pazienti.
Medtronic (NYSE: MDT) ha anunciado que publicará sus resultados financieros del tercer trimestre del año fiscal 2025 el martes 18 de febrero de 2025. El comunicado de ganancias estará disponible a las 5:45 a.m. CST, seguido de una transmisión de video a las 7:00 a.m. CST para discutir los resultados del trimestre que terminó el 24 de enero de 2025.
La compañía también ha delineado su calendario de publicación de ganancias, incluidos los resultados del Q4 FY2025 el 21 de mayo de 2025, y resultados trimestrales para FY2026 programados para el 19 de agosto de 2025, 18 de noviembre de 2025, 17 de febrero de 2026 y 20 de mayo de 2026.
Medtronic, con sede en Galway, Irlanda, es una empresa global de tecnología de la salud con más de 95,000 empleados en más de 150 países. Sus tecnologías tratan 70 condiciones de salud, incluidos dispositivos cardíacos, robótica quirúrgica, bombas de insulina y sistemas de monitoreo de pacientes.
메드트로닉 (NYSE: MDT)은 2025 회계연도 3분기 재무 결과를 2025년 2월 18일 화요일에 발표할 것이라고 발표했습니다. 실적 발표는 CST 시간 기준으로 오전 5시 45분에 제공되며, 2025년 1월 24일에 종료된 분기의 결과에 대해 논의하는 동영상 웹캐스트가 CST 시간 기준으로 오전 7시에 진행될 예정입니다.
회사는 또한 다가오는 실적 발표 일정도 마련했으며, 2025년 5월 21일에 FY2025 4분기 결과를 발표하고, 2026년 FY에 대한 분기 실적은 2025년 8월 19일, 2025년 11월 18일, 2026년 2월 17일 및 2026년 5월 20일에 예정되어 있습니다.
메드트로닉은 아일랜드 갈웨이에 본사를 두고 있으며, 150개 이상의 국가에서 95,000명 이상의 직원이 근무하는 글로벌 의료 기술 기업입니다. 그들의 기술은 심장 장치, 수술 로봇, 인슐린 펌프 및 환자 모니터링 시스템을 포함하여 70가지 건강 상태를 치료합니다.
Medtronic (NYSE: MDT) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre de l'exercice 2025 le mardi 18 février 2025. Le communiqué de résultats sera disponible à 5h45 CST, suivi d'un webcast vidéo à 7h00 CST pour discuter des résultats du trimestre qui s'est terminé le 24 janvier 2025.
L'entreprise a également présenté son calendrier de publication des résultats, y compris les résultats du T4 FY2025 le 21 mai 2025, et les résultats trimestriels pour FY2026 prévus pour le 19 août 2025, 18 novembre 2025, 17 février 2026 et 20 mai 2026.
Medtronic, dont le siège est à Galway, Irlande, est une entreprise mondiale de technologie de la santé avec plus de 95 000 employés dans plus de 150 pays. Leurs technologies traitent 70 conditions de santé, y compris des dispositifs cardiaques, de la robotique chirurgicale, des pompes à insuline et des systèmes de surveillance des patients.
Medtronic (NYSE: MDT) hat angekündigt, dass es am Dienstag, dem 18. Februar 2025, seine Finanzergebnisse für das dritte Quartal des Geschäftsjahres 2025 veröffentlichen wird. Die Gewinnveröffentlichung wird um 5:45 Uhr CST verfügbar sein, gefolgt von einem Video-Webcast um 7:00 Uhr CST, um die Ergebnisse für das am 24. Januar 2025 abgeschlossene Quartal zu diskutieren.
Das Unternehmen hat auch seinen bevorstehenden Zeitplan zur Veröffentlichung von Gewinnen skizziert, einschließlich der Ergebnisse für das Q4 FY2025, die am 21. Mai 2025 veröffentlicht werden, und der vierteljährlichen Ergebnisse für FY2026, die für den 19. August 2025, 18. November 2025, 17. Februar 2026 und 20. Mai 2026 geplant sind.
Medtronic hat seinen Sitz in Galway, Irland, und ist ein globales Gesundheits-technologieunternehmen mit über 95.000 Mitarbeitern in über 150 Ländern. Ihre Technologien behandeln 70 Gesundheitszustände, darunter Herzgeräte, chirurgische Robotik, Insulinpumpen und Patientenüberwachungssysteme.
- None.
- None.
Medtronic will host a video webcast at 7:00 a.m. CST on February 18, 2025, to discuss results for its third quarter of full fiscal year 2025. The webcast can be accessed at https://investorrelations.medtronic.com.
Within 24 hours of the broadcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at https://investorrelations.medtronic.com.
Looking ahead, Medtronic plans to report its fourth quarter fiscal year 2025 results on Wednesday, May 21, 2025. For fiscal year 2026, Medtronic plans to report its first, second, third, and fourth quarter results on Tuesday, August 19, 2025, November 18, 2025, February 17, 2026, and Wednesday, May 20, 2026, respectively. For these events, confirmation and additional details will be provided closer to the specific event.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Contacts: | |
Erika Winkels | Ryan Weispfenning |
Public Relations | Investor Relations |
+1-763-526-8478 | +1-763-505-4626 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-to-announce-financial-results-for-its-third-quarter-of-fiscal-year-2025-302369035.html
SOURCE Medtronic plc
FAQ
When will Medtronic (MDT) report Q3 FY2025 earnings?
What is the earnings release schedule for Medtronic (MDT) in FY2026?
When did Medtronic's (MDT) Q3 FY2025 quarter end?